ARCHIVES

Pretreatment with Azacitidine Achieves 28-Month Remission

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Surgery Without Radiation Found Inadequate for DCIS

December 26, 2003

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

May 27, 2005